Le Lézard
Classified in: Health
Subject: PLW

Ranir Obtains Rights to P&G Tooth Whitening Strip Patents


GRAND RAPIDS, Mich., March 13, 2018 /PRNewswire/ -- Ranir, LLC today announced that a resolution has been reached between P&G and Ranir regarding P&G patent rights and Ranir's tooth whitening strip products.  P&G is the owner or licensee of many patents relating to tooth whitening strip technology.

On March 20, 2017, P&G filed a patent infringement lawsuit against Ranir, asserting infringement of U.S. Patent Nos. 5,891,453 and 5,894,017 with respect to certain Ranir tooth whitening strip products.  P&G and Ranir have worked together to negotiate a mutually-agreeable resolution to the underlying dispute, as well as new disputes related to P&G's significant patent portfolio that includes broad patent coverage of tooth whitening strips for years to come.  Although the specific terms of the settlement are confidential, the agreement resolves all known patent disputes between P&G and Ranir in the U.S. and in Canada regarding tooth whitening strip products.  As part of the settlement agreement, Ranir agreed to certain confidential commercial terms in exchange for rights to P&G patents that allow Ranir to remain in the tooth whitening strip market. 

About Ranir

Ranir is a leading global manufacturer of store brand private label consumer oral care products, including power and manual toothbrushes, teeth whiteners, dental floss and flossers.  Founded in 1979, Grand Rapids, Michigan-based Ranir serves retail customers globally and is committed to delivering affordable, healthy smiles in millions of households every day. Its products, which include some of the world's largest oral care store brands, can be found at major retailers in more than 40 countries.  The consumer and customer insight driven research and development-focused company also owns, manufactures and markets the Plackers® and REMBRANDT® brands and proudly employs more than 750 associates worldwide.  For more information, visit www.ranir.com.

 

SOURCE Ranir, LLC


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to...

at 16:05
Personalis, Inc. , a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time. About Personalis, Inc....

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...

at 16:05
Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

at 16:05
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...



News published on and distributed by: